Earlier this week, Nuclear Medicine Europe, the European Industry Association for Nuclear Medicine, held their yearly general assembly, at which Daniel Rossetto introduced ARTBIO as a new member.
ARTBIO is proud to partner with Nuclear Medicine Europe to raise awareness and advance #nuclearmedicine in the region. We are committed to redefining cancer care as we develop a new class of #alpha#radioligand therapies as well as their ecosystem that maximizes their potential.
#Pb212#radioligandtherapy#RLT#biotech#ART
"💥 Fueling the Future: Exploring the Global Nuclear Medicine/Radiopharmaceuticals Market 🌐
Nuclear medicine and radiopharmaceuticals are revolutionizing healthcare by enabling precise diagnostics and targeted therapies. The global market is witnessing incredible advancements.
Join me in discussing the latest breakthroughs, key players, and the profound impact of nuclear medicine on healthcare worldwide. Let's connect and dive into the exciting possibilities this field offers. #NuclearMedicine#Radiopharmaceuticals#HealthcareInnovation"
Get more info: https://shorturl.at/mox46
🇲🇽Nuclear Medicine Physician/Professor, 🚀Leader Entrepreneur,💼 Business promoter & 💡Scientific adviser. Focused on private sector Molecular Imaging and Nuclear Medicine in Mexico.
We are doing great disruptive commercial things as businessmen in Nuclear Medicine & Molecular Imaging field, obviously by private sector! 🇲🇽🙌🏼🚀🏆🥇📈 | The MedicinaNuclearMX collective are Mexican Nuclear Medicine Physicians promoting, expanding clinical use & doing business by private sector in Mexico. #nuclearmedicine#molecularimaging#theranostics#radionuclidetherapy
🚀 Sharing radiopharmaceutical insights 🚀
Radiopharmaceuticals are an emerging and innovative therapeutic class in the anti-cancer market.
Recently, Federico Mambretti, the Country President at Novartis Belux, recognized this potential and visited the renowned Belgian radiopharmaceutical research center SCK CEN. In this video, Prof. Sarah Baatout, Deputy Institute Director Nuclear Medical Applications, explains the importance of radiopharmaceuticals.
We, ZTI, are also developing cutting-edge radiopharmaceuticals. In line with Novartis's interest, we would like to share insights about RLT, a specific type of radiopharmaceutical that has been garnering attention.
#Novartis#SCKCEN#RLT#Radiopharmaceuticals#Cancer#ODD#ADC#Antibody#RadioAntibodyConjugate#RAC#Nanotech#DDS#Platform#alphatherapy#FDA#IND and #ZTIBIOSCIENCES 🌐
In our new video series with SCK CEN – the Belgian Nuclear Research Centre – our Country President Federico Mambretti explores nuclear medicine and the way treatments such as radioligand therapy (RLT) are being used to target and eradicate cancer cells while limiting the impact on nearby healthy cells. 🎯
Learn more about what RLT is, as well as what the difference is between RLT and chemotherapy in the clip below - with special thanks to Prof. Sarah Baatout, Deputy Institute Director Nuclear Medical Applications, for sharing her clear insights with us 🤝
Curious to know more?
NL 👉 https://lnkd.in/eVgCPHSW
FR 👉 https://lnkd.in/eHvjCaeB
🇲🇽Nuclear Medicine Physician/Professor, 🚀Leader Entrepreneur,💼 Business promoter & 💡Scientific adviser. Focused on private sector Molecular Imaging and Nuclear Medicine in Mexico.
#alasbimn 2023 is approaching… if you want to learn how to be an Independent Nuclear Medicine Physician… reach me! | The MedicinaNuclearMX collective are Mexican Nuclear Medicine Physicians promoting, expanding clinical use & doing disruptive business by private sector in Mexico. #nuclearmedicine#molecularimaging#radionuclidetherapy#theranostics
Novartis - RLT Supply Chain
1moI am excited to see the opportunities your distributed manufacturing strategy will unlock, especially the positive impact it will have for patients!